mrp vector (Univ de Louvain)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemrp vector (Univ de Louvain)
Drug Alias Namemultidrug resistance vector (Louvain)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversite Catholique De Louvain
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversite Catholique De Louvain
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A